Page URL:

HIV drugs can lead to premature ageing of mitochondrial DNA

4 July 2011
Appeared in BioNews 614

New research has revealed that a group of generic anti-HIV drugs may be linked to premature ageing. The study, which was carried out by UK scientists at the Institute of Genetic Medicine at Newcastle University, could explain why people treated with this class of drugs sometimes show signs of age-related conditions, such as heart disease and dementia.

The researchers studied muscle cells taken from people with HIV (human immunodeficiency virus) who had previously taken drugs known as nucleoside analogue reverse-transcriptase inhibitors (NRTIs) and found that DNA in the mitochondria of their cells had accumulated a number of errors that was more comparable to healthy people 20 or 30 years older.

'The DNA in our mitochondria gets copied throughout our lifetimes and, as we age, naturally accumulates errors. We believe that these drugs accelerate the rate at which these errors build up', said Professor Patrick Chennery, who led the study, adding: 'Over the space of, say, ten years, a person's mitochondrial DNA may have accumulated the same amount of errors as a person who has natural aged twenty or thirty years'.

NRTIs were a major breakthrough in the battle against HIV when they were developed in the late 1980s. But side-effects such as premature ageing and frailty have meant that they have been replaced by a cocktail of more recent drugs. However, NRTIs are generally favoured over these new drugs in developing countries due to their lower costs.

Until now it has not been clear why NRTIs, which include AZT or zidovudine, have these side-effects. 'HIV clinics were seeing patients who had otherwise been successfully treated but who showed signs of being much older than their years. This was a real mystery', said Professor Chinnery, 'but colleagues recognised many similarities with patients affected by mitochondrial diseases... and referred them to our clinic'.

Defects in mitochondrial DNA are often seen in age-related conditions, although it is not yet known whether this is a cause or consequence of taking the drugs.

It was estimated in 2009 that 33.3 million people had HIV, and of these 22.5 million live in Africa. The researchers were keen to stress that while NRTIs do sometimes have side-effects, not taking them would be worse: 'These drugs may not be perfect, but we must remember that when they were introduced they gave people an extra ten or twenty years when they would otherwise have died. In Africa, where the HIV epidermis has hit hardest and where more expensive medications are not an option, they are an absolute necessity', said Dr Brendan Payne, a co-author of the study.

The researchers will now look at how the damage believed to be caused by the drugs can be repaired. The study was published in Nature Genetics.

AIDS drugs can cause premature ageing: study
Reuters |  27 June 2011
Drugs used to treat HIV 'causes premature ageing'
Daily Mail |  27 June 2011
Mitochondrial aging is accelerated by anti-retroviral therapy through the clonal expansion of mtDNA mutations
Nature Genetics |  26 June 2011
Premature ageing caused by some HIV drugs, study shows
Newcastle Biomedicine press release |  26 June 2011
28 January 2013 - by Matthew Thomas 
Altering the genetic makeup of immune cells could provide them with resistance to HIV...
13 August 2012 - by Dr Linda Wijlaars 
Scientists working on fruit flies say their work provides an answer to the question of why women tend to live longer than men. The research points to mitochondria, the 'batteries' within cells that generate energy, as hotspots for mutations that negatively affect male health...
30 July 2012 - by Dr Daniel Grimes 
Scientists have discovered that an anti-cancer drug can revive dormant HIV thereby allowing therapies to act upon the low level inactive virus particles that hide in patients' immune cells and have, until now, been unsusceptible to treatment...
11 June 2012 - by Catherine Murphy 
As the UK's largest HIV charity, Terrence Higgins Trust warmly welcomes the decision by the National Institute for Health and Clinical Excellence (NICE) last month to consult on an updated version of its fertility guideline. The new approach outlined by NICE holds the potential to transform fertility services for men and women living with or affected by HIV in the UK who want to become parents...
1 August 2011 - by Dr Marianne Kennedy 
The rate at which we age depends on socio-economic status and can be revealed by a DNA test, which will improve assessment of public health measures, say Glaswegian scientists....
7 March 2011 - by Dr Lux Fatimathas 
American researchers have successfully created immune cells resistant to HIV. T cells, which are the main target of HIV, were isolated from six HIV positive patients and genetically manipulated to confer resistance. The cells were injected back into the same patients and were able to survive and multiply...
21 June 2010 - by Dr Lux Fatimathas 
A human RNA-based gene therapy trial to combat HIV has passed the first safety test. US researchers modified human blood stem cells to make them resistant to the virus....
7 August 2009 - by Dr Aubrey de Grey 
The relevance of nearly all biogerontology research to combating aging is restricted to the potential for slowing down the accumulation of molecular and cellular damage that eventually leads to age-related ill-health. Meanwhile, regenerative medicine has been progressing rapidly and is nearing clinical applicability to a wide range of specific conditions...
21 July 2008 - by Evelyn Harvey 
A form of a gene that protects many Africans from certain forms of malaria increases HIV infection risk, according to a new study published in the journal Cell Host and Microbe. Researchers Professor Sunil K Ahuja, from The University of Texas Health Science Center at San Antonio...
9 June 2008 - by MacKenna Roberts 
The UK Parliament's rejection of an amendment to new fertility legislation could delay the only potential new treatment for a class of roughly 50 devastating inherited metabolic disorders from becoming available for possibly years beyond when the technology is proven safe and effective for clinical use, according...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.